证券代码：688305 证券简称：科德数控 公告编号：2025-008 科德数控股份有限公司 关于公司 2024 年度募集资金存放与实际使用情况的 专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会（以下简称"中国证监会"）《上市公司监管 指引第 2 号——上市公司募集资金管理和使用的监管要求》（以下简称"《上市 公司监管指引第 2 号》"）、《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》（以下简称"《规范运作》"）的相关规定，科德数控股份 有限公司（以下简称"公司"）就 2024 年度募集资金存放与实际使用情况作如 下专项报告： 一、募集资金基本情况 （一）募集资金金额、资金到位情况 1、根据中国证监会出具的《关于同意科德数控股份有限公司首次公开发行 股票注册的批复》（证监许可〔2021〕1590 号），公司首次向社会公众公开发 行人民币普通股（以下简称"首次公开发行股票"）22,680,000 股，每股发行 价格为人民币 11.03 元，共募集资金人民币 250,1 ...

科德数控股份有限公司 非经营性资金占用及其他关联资金往来情况的专项报告 信会师报字 [2025]第 ZG11948 号 科德数控股份有限公司 非经营性资金占用及其他关联资金往来情况的专项报告 | | 目 录 | 页 次 | | --- | --- | --- | | 一、 | 非经营性资金占用及其他关联资金往来情况的专项报告 | 1-2 | | 二、 | 非经营性资金占用及其他关联资金往来情况汇总表 | 1-2 | 关于科德数控股份有限公司 非经营性资金占用及其他关联资金往来情况 的专项报告 信会师报字[2025]第 ZG11948 号 科德数控股份有限公司全体股东： 我们审计了科德数控股份有限公司(以下简称"贵公司")2024 年 度的财务报表，包括 2024 年 12 月 31 日的合并及母公司资产负债表、 2024 年度合并及母公司利润表、合并及母公司现金流量表、合并及 母公司所有者权益变动表和相关财务报表附注，并于 2025 年 4 月 27 日出具了报告号为信会师报字[2025]第 ZG11946 号的无保留意见审 计报告。 贵公司管理层根据中国证券监督管理委员会《上市公司监管指引 第 8 号——上 ...

科德数控股份有限公司 募集资金存放与实际使用情况鉴证报告 信会师报字[2025]第 ZG11949 号 科德数控股份有限公司 募集资金存放与实际使用情况鉴证报告 目 录 | 一、 | 2024 年度募集资金存放与实际使用情况专项报告的鉴证报告 | 1-2 | | --- | --- | --- | | 二、 | 2024 年度募集资金存放与实际使用情况专项报告 | 1-8 | | 三、 | 附件 1 ：募集资金使用情况对照表（首次公开发行股票） | | | 四、 | 附件2 ：募集资金使用情况对照表（2022 年度向特定对象发行股票） | | | 五、 | 附表 3：募集资金使用情况对照表（2023 年度向特定对象发行股票） | | 关于科德数控股份有限公司 2024年度 募集资金存放与实际使用情况专项报告的鉴证报告 信会师报字[2025]第ZG11949号 科德数控股份有限公司全体股东： 我们接受委托，对后附的科德数控股份有限公司（以下简称"贵 公司"） 2024年度募集资金存放与实际使用情况专项报告（以下简称 "募集资金专项报告"）执行了合理保证的鉴证业务。 一、董事会的责任 贵公司董事会的责任是按照中国 ...

证券代码：688305 证券简称：科德数控 公告编号：2025-009 日常关联交易对上市公司的影响：本次预计的关联交易属于公司及控股 子公司的日常关联交易事项，为公司正常生产经营及业务发展所需，遵循公平、 公正、公允的市场化定价原则，不存在损害公司及全体股东尤其是中小股东利益 的情形，公司主营业务收入、利润来源不存在依赖该类关联交易及关联方的情况， 日常关联交易不会对公司的独立性构成不利影响。 一、日常关联交易基本情况 科德数控股份有限公司 关于公司 2025 年度日常关联交易预计的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 科德数控股份有限公司（以下简称"公司"或"本公司"）本次日常关 联交易预计事项，需提交股东大会审议。 （一）日常关联交易履行的审议程序 1、独立董事专门会议审议情况 2025 年 4 月 27 日，公司召开第三届董事会独立董事专门会议 2025 年第二 次会议，全体独立董事一致审议同意《关于公司 2025 年度日常关联交易预计的 议案》，并同意将该议案提交第三届董事会第十八 ...

科德数控公告，2024年营业收入为6.05亿元，同比增长33.88%。归属于上市公司股东的净利润为1.3亿 元，同比增长27.37%。公司拟向全体股东每10股派发现金红利人民币2.45元(含税)，同时以资本公积金 向全体股东每10股转增3股，不送红股。 ...

证券之星消息，4月28日科德数控(688305)跌6.99%，收盘报74.78元，换手率3.11%，成交量3.16万手， 成交额2.43亿元。该股为智能制造、工业自动化、军民融合、军工、机器人、大飞机、人形机器人、工 业母机概念热股。4月28日的资金流向数据方面，主力资金净流出3170.85万元，占总成交额13.03%，游 资资金净流入636.1万元，占总成交额2.61%，散户资金净流入2534.75万元，占总成交额10.41%。融资 融券方面近5日融资净流入823.39万，融资余额增加；融券净流入426.0，融券余额增加。 重仓科德数控的公募基金请见下表： | 基金筒称 | 基金代码 | 持有股数 | 持仓变动 | 数据来源 | | --- | --- | --- | --- | --- | | 科创板长城 | 506008 | 9.50万股 | 新进十大 | 2025基金01季报 | | 人保行业轮动混合A | 006573 | 1.02万股 | 減せ | 2025基金01季报 | | 建信开元金享6个月持有期债券发起A | 020724 | 0.50万股 | 新进十大 | 2025基金Q1季报 | 科创 ...

Group 1: Zhongjian Technology - The management emphasizes high-quality and sustainable development, aligning with national strategies and the real economy [1] - Over 90% of overseas sales are from the European region, with limited and controllable impact from U.S. tariff policy adjustments [1] - The "mowing robot" developed by subsidiary Shanghai Gaike has received small batch orders, showcasing its advanced features [1] - A subsidiary in Thailand is set up in 2024, and the construction of the smart manufacturing center is progressing steadily [1] Group 2: Zhongke Lanyun - The product line has expanded to include ten categories, such as Bluetooth headset chips and Bluetooth speaker chips [2] - The non-net profit for 2024 is expected to grow by 40.44% year-on-year, driven by a rich product variety and increased sales volume [2] - In 2025, the company plans to develop audio chips for smart speakers, smartwatches, and R/VR devices, along with launching Wi-Fi and video product lines [2] - Collaborations with ByteDance's Volcano Engine have led to solutions compatible with the Doubao large model [2] Group 3: Kede CNC - The company has minimal exposure to U.S. tariffs as its core technology and components are not sourced from the U.S. [3] - Focus on independent R&D of key components has led to the successful development of five-axis CNC systems and servo drives [3] - Orders are driven by both repurchases of old models and the expansion of new products, with a 13% increase in traditional five-axis vertical machining center orders [3] Group 4: Xujie Electric - In 2024, the company achieved revenue of 17.089 billion yuan and a net profit of 1.117 billion yuan, marking an 11.09% year-on-year increase [4] - The revenue structure has been optimized, with a decline in low-margin new energy and system integration segments, while high-margin DC transmission revenue has grown [4] - The company has secured multiple State Grid DC transmission projects and increased orders in the Southern Grid market [4] - R&D investment reached 880 million yuan, focusing on key technologies like offshore wind power DC transmission systems [4]

Group 1: Key Points on Kede CNC - Kede CNC's core technology and component procurement do not involve U.S. origin goods, resulting in minimal impact from tariffs [1] - The company focuses on independent research and development of key functional components, achieving self-control over five-axis CNC systems, servo drives, and motors [1] - Orders are driven by both repurchases of old models and the expansion of new products, with a 13% increase in traditional five-axis vertical machining center orders and a 40% repurchase rate for machine tool products [1] - The five-axis horizontal machining centers and five-axis horizontal milling-turning composite machining centers have diverse specifications suitable for processing complex structural parts, significantly enhancing processing efficiency and precision [1] - The blade tip grinding products contribute to increasing the localization rate of aircraft engines, promoting the rapid and high-quality development of core technologies in the aviation industry [1] Group 2: Key Points on Novogene - Novogene's overseas conventional business revenue for 2024 has exceeded 100 million yuan, accounting for 7.4% of total revenue, with significant domestic client supply chain import substitution opportunities expected to drive growth [2] - Import enterprises hold over 50% market share in research and diagnostic clients, with even higher shares in pharmaceutical companies, indicating strong domestic replacement potential [2] - The domestic gross margin has declined due to intensified competition and product structure adjustments, although the sales proportion of new product categories is increasing, with some products maintaining good gross margins [2] - Novogene collaborates comprehensively with BGI in areas such as gene sequencing and D detection, with potential for deeper cooperation in Alzheimer's disease testing in the future [2]

Investment Rating - The report suggests that humanoid robot "small brain" is expected to become an important main track for investment opportunities [4]. Core Insights - The humanoid robot "small brain" is primarily responsible for trajectory planning and motion control, consisting of controllers, servo drivers, motors, and sensors. Its development is expected to create numerous investment opportunities as the industry matures [1]. - The rapid iteration of the humanoid robot "brain" enhances the importance of the "small brain," which faces high barriers and complexity in its technological route, making breakthroughs challenging [1]. - Potential business models for the "small brain" include third-party solutions, integrated models, and deep cooperation for secondary development [2]. Summary by Sections 1. Humanoid Robot "Small Brain" as a Main Track - The "small brain" is crucial for motion control, with its complexity increasing as it needs to handle multidimensional input signals and higher degrees of freedom [1]. - The "brain" is evolving rapidly, with significant breakthroughs in technology, enhancing the "small brain's" importance in the industry [1]. 2. Potential Business Models for the "Small Brain" - Three potential business models are identified: 1. Third-party model providing standardized solutions to achieve scale [2]. 2. Integrated model focusing on motion control technology from inception [2]. 3. Deep cooperation for secondary development with leading manufacturing companies [2]. 3. Companies with Growth Opportunities in the "Small Brain" Sector - Companies with high-end equipment capabilities and multi-axis control, such as Solid High Technology, Huazhong CNC, and Kede CNC, are well-positioned for growth [3]. - Companies with industrial robot motion control capabilities, like Tuosida, Aifute, and Estun, are also expected to extend their offerings into the humanoid robot sector [3]. 4. Investment Recommendations - The report recommends focusing on companies with relevant technological reserves, particularly Huazhong CNC and Kede CNC, due to the significant growth potential in the humanoid robot sector [4].

Investment Rating - The report assigns a "Buy" rating for the company, indicating a positive outlook for potential price appreciation [3][8]. Core Insights - The company is a leading innovative enterprise in the domestic high-end CNC machine tool sector, with a dual R&D system for high-end CNC systems and five-axis CNC machine tools, benefiting from the rapid growth of industries such as aerospace and new energy vehicles [3]. - The company has achieved significant revenue and profit growth, with a CAGR of 34.9% from 2017 to 2024, and a net profit CAGR of 51.6% during the same period [3]. - The domestic high-end manufacturing upgrade and equipment renewal are driving the growth of the five-axis CNC machine tool industry, with increasing demand from the aviation sector [3][5]. - The company has successfully achieved domestic substitution for high-end machine tools, with a self-sufficiency rate of 85% for five-axis CNC machine tools [5]. - The company maintains a gross margin of 42%, significantly higher than the industry average of 25.4%, due to its focus on high-end products and self-developed core components [5]. Summary by Sections Company Overview - The company specializes in high-end CNC machine tools, with a product matrix that includes various types of machining centers and specialized processing centers [3]. - The company has a market capitalization of 77.92 billion yuan and a current share price of 76.62 yuan, with a target price set at 90 yuan [1]. Financial Performance - Revenue is projected to grow from 605 million yuan in 2024 to 1,006 million yuan in 2026, with net profit expected to increase from 130 million yuan in 2024 to 218 million yuan in 2026 [7][9]. - The company’s earnings per share (EPS) is forecasted to rise from 1.28 yuan in 2024 to 2.15 yuan in 2026, reflecting strong growth potential [7]. Market Position - The company is positioned to benefit from the increasing demand for high-end CNC machine tools in the domestic market, particularly in the aerospace sector, which is expected to see significant growth in the coming years [3][5]. - The company has a robust order book, with new orders increasing by 24% year-over-year in 2024, indicating strong market demand [5].